Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Telmisartan vs valsartan vs losartan in diabetic nephropathy
IRCT20250711066450N1Phase 3Completed
- Sponsor
- Zanjan University of Medical Sciences
- Start
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of telmisartan, valsartan and losartan in diabetic glomerulosclerosis (3 arms), sponsored by Zanjan University of Medical Sciences. Started Oct 2025; status: completed.
02
Drugs
telmisartanvalsartanlosartan
03
Conditions
diabetic glomerulosclerosis
Beyond the preview
Go deeper on IRCT20250711066450N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250711066450N1.